Guest

nDatalyze Corp. updates the "Epitome" Predictive Sports Performance Analytics Project and the RTO progress

Date/time : 2025-09-30 10:25 AM
Symbol :

NDAT

Company : nDatalyze Corp Com
Price : 0.015
Market cap : 619,911
O/S : 41,327,425
Exchange :

CSE

Industry :

Healthcare Information Services

Full story

nDatalyze Corp. updates the "Epitome" Predictive Sports Performance Analytics Project and the RTO progress

(TheNewswire)

nDatalyze Corp.

Calgary, Alberta – TheNewswire - September 30, 2025 – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE: NDAT) (OTCQB: NDATF) is pleased to announce that the sports analytics predictive scoring formulas, including genetic markers, are now in testing and calibration. The Epitome online questionnaire is now “live” and is also in testing. Data collection from three junior league teams (WHL and equivalent) is expected to begin around the middle of October and be completed before year-end, 2025. Machine learning has been an instrumental tool in all aspects of Epitome and has significantly reduced costs and accelerated development time.

Regarding the previously announced RTO, the Corporation has been informed that the RTO target audit is ongoing and that the controlling shareholder is awaiting a tax opinion prior to finalizing the amount of the contemplated private placement. It is unknown when the tax opinion will be received. Trading in the Corporation’s shares will remain halted until the RTO is completed or abandoned.

For Further Information, please contact:

Jim Durward, President, CEO/CTO

Email: jimd@ndatalyze.com

nDatalyze Website: https://www.ndatalyze.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.

Copyright (c) 2025 TheNewswire - All rights reserved.